Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1997-04-30
1998-04-14
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 48, 536 2622, 536 2623, A61K 3170
Patent
active
057391203
ABSTRACT:
The present invention relates to new liponucleotide analog compounds having useful antiviral activity, represented by general formula (I): ##STR1## wherein R.sup.1 is a saturated or unsaturated alkyl having 6-22 C atoms; R.sup.2 is a saturated or unsaturated alkyl having 12-20 C atoms; R.sup.3 and R.sup.4 are each hydrogen or hydroxy; and B is one of the nucleoside bases of formula (a): ##STR2## wherein R.sup.5 is a hydrogen, halogen, hydroxy, amino, mercapto, or C.sub.1 -C.sub.4 alkyl amino; R.sup.6 is a hydrogen, halogen or amino; W is a nitrogen or C--R.sup.8 where R.sup.8 is hydrogen, halogen, amino or C.sub.1 -C.sub.4 alkyl, and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 3321463 (1967-05-01), Moffatt
patent: 3787392 (1974-01-01), Bergmeyer et al.
patent: 3803125 (1974-04-01), Bergmeyer et al.
patent: 3872083 (1975-03-01), Okutsu et al.
patent: 4291024 (1981-09-01), Turcotte
patent: 4471113 (1984-09-01), MacCoss et al.
patent: 4622392 (1986-11-01), Hong et al.
patent: 5159067 (1992-10-01), Schinazi et al.
MacCoss et al., "The Synthesis, Characterization and Preliminary Biological Evaluation of 1-.beta.-D-Arabinofuranosylcytosine-5'-Diphosphate-L-1,2-dipalmitin," Biochem. Biophys. Res. Comm., 85(2), 714-723 (1978).
Ryu et al., "Phospholipid-Nucleoside Conjugates. 3. Synthesis and Preliminary Biological Evaluation of 1-.beta.-D-Arabinosylcytosine 5'-Diphosphate-L-1,2-dipalmitin and Selected 1-.beta.-D-Arabinosylcytosine 5'-Diphosphate-L-1,2-Diacylglycerols," J. Med. Chem., 25(11), 1322-1329 (1982).
Kumar et al., "Equal Inhibition of HIV Replication by Stereoisomers of Phosphatidyl-Azidothymidine," J. Biol. Chem., 267(28), 20288-20292 (1992).
Matsushita et al., "Phospholipid Derivatives of Nucleoside Analogs as Prodrugs with Enhanced Catabolic Stablity," Cancer Research, 41(7), 2707-2713 (1981).
Scheit, "Nucleotide Analogs. Synthesis and Biological Function," John Wiley & Sons, New York, NY, 1980, pp. 211-218.
Turcotte et al.(I), "Cytotoxic Liponucleotide Analogs. I. Chemical Synthesis of CDP-Diacylglycerol Analogs Containing the Cytosine Arabinoside Moiety," Biochim. Biophys. Acta, 619, 604-618 (1980).
Turcotte et al.(II), "Cytotoxic Liponucleotide Analogs. II. Antitumor Activity of CDP-Diacylglycerol Analogs Containing the Cytosine Arabinoside Moiety," Biochim. Biophys. Acta, 619, 619-631 (1980).
Claude Piantadosi et al. "Synthesis and Evaluation of Novel Ether Lipid Nucleoside Conjugates for Anti-HIV-1 Activity", J. Med. Chem. 1991, pp. 1408-1414., V. 34, Issue No. 4.
Louis S. Kucera et al., "Novel Membrane-Interactive Ether Lipid Analogs That Inhibit Infectious HIV-1 Production and Induce Defective Virus Formation", AID Research and Human Retroviruses, vol. 6, Apr., 1990, pp. 491-501.
Chai Hee Sang
Lee Jae Seung
Paik Woo Hyun
Shin Won Sup
Boryung Pharmaceutical Co. Ltd.
Crane L. Eric
Kight John
LandOfFree
Treatment of viral infections by administration of sylpurinyl)! does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of viral infections by administration of sylpurinyl)! , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of viral infections by administration of sylpurinyl)! will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-634677